期刊文献+

重度COPD患者几种解痉药物的临床应用比较 被引量:1

Effects of several inhaled bronchodilators on patients of severe COPD
在线阅读 下载PDF
导出
摘要 目的比较可必特气雾剂、溴化异丙托品气雾剂以及沙丁胺醇气雾剂对应用机械通气的重度慢性阻塞性肺疾病患者的支气管扩张作用。方法对60例应用机械通气的重度慢性阻塞性肺疾病患者,随机分为三组,均实施间歇正压通气呼吸模式,并在记录气道峰压、平台压、呼气峰流速、气道阻力后,分别通过雾化器吸入沙丁胺醇气雾剂(A组)、溴化异丙托品气雾剂(B组)和可必特(C组),吸入后10、30、60、180及360min后重复记录各通气参数的变化。结果C组在用药10min时气道峰压、气道阻力即有下降,呼气峰流速上升(t分别=2.73、2.46、2.28,P均<0.05)。与B组比较,差异有统计学意义(F=84.26、30.59、106.73,P<0.05),至180min时改善最为明显,至360min时气道峰压、气道阻力仍有明显下降,呼气峰流速明显上升(t分别=2.93、2.23、2.29,P均<0.05),与A组比较,差异有统计学意义(F分别=85.76、26.77、124.12,P均<0.05)。结论对应用机械通气的慢性阻塞肺疾病患者,应用可必特对支气管的扩张效果强于单用溴化异丙托品气雾剂或沙丁胺醇。 Objective To compare the effects of ipratropium bromide(IPB) , salbuta(SA) and combivent(CB) on bronchodilation in patients with severe COPD by mechanical ventilation. Methods Sixty patients, mechanically ventilated with IPPV for severe COPD, were divided into three groups. After measurement of patients' peak inspiratory pressure (PIP), plateau pressure ( Pplateau ), peak expiratory flow (PEF) and airway resistance (Raw) were noted, one group patients inhaled IPB , the other groups inhaled SA and CB respectively. PIP, Pplateau, PEF and Raw were respectively noted at the points of 10, 30, 60, 180 and 360 min after inhalation. Results In CB group, at the point of 10 minute, PIP and Raw were de- scending and PEF was ascending( t = 2.73,2.46,2.28, P 〈 0.05) ; its effect was better than IPB group at the points of 10 and 30 min( P 〈 0.05) and was increased at the points of 60, 180 and 360 min( P 〈 0.05) . Its effect was better than SA group at the points of 180 and 360 min ( P 〈 0.05) . Conclusion Effects of combivent on bronehodilation in patients mechanically ventilated for COPD was greater than IPB or SA .
出处 《全科医学临床与教育》 2007年第4期298-300,共3页 Clinical Education of General Practice
关键词 可必特 溴化异丙托品 沙丁胺醇 慢性阻塞性肺疾病 机械通气 combivent ipratropium bromide salbuta COPD mechanical ventilation
  • 相关文献

参考文献7

二级参考文献22

  • 1李靖,王红玉,钟南山.溴化异丙托品与沙丁胺醇雾化吸入对COPD病人的支气管扩张作用[J].中国实用内科杂志,1996,16(8):465-466. 被引量:39
  • 2Barnes PJ. Muscarinic receptor subtypes in airways. Life Sci,1993,52:521-527.
  • 3Eglen RM,Reddy H,Watson N,et al. Muscarinic acetylcholine receptor subtypes in smooth muscle. Trends Pharmacol Sci,1994,15:114-119.
  • 4Hansel TT,Barnes PJ. Tiotropium bromide:a novel once-daily anticholinergic bronchodilator for the treatment of COPD. Drugs Today (Barc),2002,38:585-600.
  • 5Littner MR,Ilowite JS,Tashkin DP,et al. Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med,2000,161(4 Pt 1):1136-1142.
  • 6Casaburi R,Briggs DD Jr,Donohue JF,et al. The spirometric efficacy of once-daily dosing with tiotropium in stable COPD:a 13-week multicenter trial. The US Tiotropium Study Group. Chest,2000,118:1294-1302.
  • 7Casaburi R,Mahler DA,Jones PW,et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J,2002,19:217-224.
  • 8Calverley PM,Lee A,Towse L,et al. Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease. Thorax,2003,58:855-860.
  • 9Tashkin D,Kesten S. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses. Chest,2003,123:1441-1449.
  • 10Donohue JF,van Noord JA,Bateman ED,et al. A 6-month,placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest,2002,122:47-55.

共引文献35

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部